Russia’s coronavirus ‘vaccine’ announced by Vladimir Putin is shrouded in secrecy – but don’t dismiss it just yet, writes BEN SPENCER By Ben Spencer for the Daily Mail Published: 23:24 BST, 11 August 2020 | Updated: 01:47 BST, 12 August 2020 Russia‘s claims to have created the world’s first coronavirus vaccine should not be dismissed … Read more
Britain will have to pay almost £2,000-per-patient for one of the only two approved Covid-19 drugs, it was revealed today. Gilead Sciences announced it would charge governments of developed countries $390 (£320) per vial of remdesivir. Most hospitalised patients will need six vials of the Ebola drug — equating to $2,340 (£1,900) for every patient, … Read more
Britain’s youngest Covid-19 survivor: Parents’ joy as three-months premature Emmanuel wins a 47-day fight with the virus before he was even due to be born Three-month-old Emmanuel Boateng is believed to be UK’s youngest survivor He spent nearly two months in hospital on a ventilator to help him breathe Emmanuel was born at just 27 weeks and taken to … Read more
Coronavirus patients in hospital may be 65 per cent more likely to see their condition improve if they are given the antiviral drug remdesivir, its manufacturer claims. Gilead Sciences, a California-based company that developed the drug in a bid to tackle Ebola, today reported the promising results for Covid-19 patients. After 11 days patients taking … Read more
Coronavirus patients in hospital may be 65 per cent more likely to see their condition improve if they are given the antiviral drug remdesivir, its manufacturer claims. Gilead Sciences, a California-based company that developed the drug in a bid to tackle Ebola, today reported the promising results for Covid-19 patients. After 11 days patients taking … Read more
Health chiefs grant NHS emergency access to give severely ill Covid-19 patients promising Ebola drug remdesivir Remdesivir has been trialled in NHS hospitals for weeks and shown promise It is a generic virus-destroying drug initially made in a bid to tackle Ebola NHS doctors will now be able to prescribe it to any critically ill … Read more
A 14-year-old boy left critically ill by the coronavirus has survived his ordeal after being given the Ebola drug remdesivir, his family have revealed. Jacob Tayel, from Ipswich, fell ill with what his mother assumed was a chest infection in March, and his 11-year-old brother, Isaac, was ill at the same time. Dianne, their mother, … Read more
Gilead Sciences Inc says it is planning to work with international partners to boost production of its experimental coronavirus drug remdesivir. On Friday, the US Food and Drug Administration (FDA) issued emergency use authorization for the medication made by the California-based company. Remdesivir, which was originally developed as an Ebola drug, is given to hospitalized … Read more
The antiviral remdesivir has shown promise for treating coronavirus, and the head of the drug’s maker, Gilead Sciences, said he’s committed to ensuring anyone who needs the drug will have access to it. ‘We’re going to work very closely with the government and with health care systems to make sure that it’s accessible, that it’s … Read more
President Donald Trump announced Friday that the FDA has approved the experimental drug remdesivir for emergency use in hospitalized coronavirus patients. It is the first drug shown to help fight the disease, which has killed more than 64,000 people in the United States. Gilead’s chief executive officer Daniel O’Day, whose company produces remdesivir joined President Trump, … Read more
Gilead Sciences said that it has capacity to make enough doses of its drug remdesivir for ‘several million treatment courses’ next year in a Thursday press release announcing its first quarter earnings. ‘As Gilead continues to work with international partners to expand production, Gilead announced it anticipates more than one million treatment courses will be … Read more
On the heels of an early announcement that coronavirus patients given Gilead’s Ebola drug remdesivir fared better than those who didn’t get the treatment, the company’s CEO, Daniel O’Day, deemed the results a cause for ‘hope at a time when it is badly needed,’ in an open letter obtained by Fox News. ‘Positive data’ from … Read more
The US may approve emergency use of an Ebola drug today after one Oxford academic hailed its trial as a ‘fantastic result’ in the fight against COVID-19. Remdesivir, an antiviral made by California-based Gilead Sciences, was shown to slash recovery times in a global trial of more than 1,000 patients, including Britons. Anthony Fauci, America’s top … Read more